Literature DB >> 29048923

Protocol Design for Large-Scale Cross-Sectional Studies of Surveillance of Risk Factors of Non-Communicable Diseases in Iran: STEPs 2016.

Shirin Djalalinia1, Mitra Modirian2, Ali Sheidaei3, Moein Yoosefi2, Hossein Zokaiee2, Bahman Damirchilu2, Zohreh Mahmoudi2, Negar Mahmoudi2, Mohammad Javad Hajipour4, Niloofar Peykari1, Nazila Rezaei2, Rosa Haghshenas2, Mohammad Hossein Mohammadi2, Alireza Delavari5, Mohammad Mehdi Gouya6, Shohreh Naderimagham2, Ahmad Kousha7, Alireza Moghisi7, Alireza Mahdavihezaveh7, Kambiz Abachizadeh8, Reza Majdzadeh9, Ali Akbar Sayyari7, Reza Malekzadeh5, Bagher Larijani10, Farshad Farzadfar2.   

Abstract

INTRODUCTION: The rise in non-communicable diseases (NCDs) has gained increasing attention. There is a great need for reliable data to address such problems. Here, we describe the development of a comprehensive set of executive and scientific protocols and instructions of STEPs 2016. METHODS/
DESIGN: This is a large-scale cross-sectional study of Surveillance of Risk Factors of NCDs in Iran. Through systematic proportional to size cluster random sampling, 31,050 participants enrolled in three sequential processes, of completing questionnaires; physical measurements, and lab assessment.
RESULTS: Out of 429 districts, samples were taken from urban and rural areas of 389 districts. After applying sampling weight to the samples, comparing the distribution of population and samples, compared classification was determined in accordance with the age and sex groups. Out of 31,050 expected participants, 30,541 participant completed questionnaires (52.31% female). For physical measurements and lab assessment, the cases included 30,042 (52.38% female) and 19,778 (54.04% female), respectively. DISCUSSION: There is an urgent need to focus on reviewing trend analyses of NCDs.To the best of our knowledge, the present study is the first comprehensive experience on systematic electronic national survey. The results could be also used for future complementary studies.

Entities:  

Mesh:

Year:  2017        PMID: 29048923     DOI: 0172009/AIM.009

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  29 in total

1.  World diabetes day: celebrating two decades of Progress in combating diabetes and its complications in Iran.

Authors:  Fatemeh Bandarian; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2019-11-26

2.  Is salt intake reduction a universal intervention for both normotensive and hypertensive people: a case from Iran STEPS survey 2016.

Authors:  Ali Gholami; Shahabeddin Rezaei; Leila Moosavi Jahromi; Hamid Reza Baradaran; Ali Ghanbari; Shirin Djalalinia; Nazila Rezaei; Shohreh Naderimagham; Mitra Modirian; Negar Mahmoudi; Zohreh Mahmoudi; Mohammad Javad Hajipour; Ahmad Kousha; Siamak Mirab Samiee; Farshad Farzadfar
Journal:  Eur J Nutr       Date:  2019-12-04       Impact factor: 5.614

3.  Assessing the effect of socioeconomic factors on prevalence of dyslipidemia among iranian adult population; district level analysis from 2016 STEPS national study using small area estimation.

Authors:  Hamidreza Soleimani; Erfan Ghasemi; Sahar Saeedi Moghaddam; Sina Azadnajafabad; Negar Rezaei; Masoud Masinaei; Shohreh Naderimagham; Nazila Rezaei; Mohammad-Reza Malekpour; Mohammad Keykhaei; Fateme Gorgani; Ameneh Kazemi; Saba Tahmasebi; Rashed Makhdoom; Farshad Farzadfar
Journal:  J Diabetes Metab Disord       Date:  2022-04-05

4.  Estimating the attributable risk of vascular disorders in different ranges of fasting plasma glucose and assessing the effectiveness of anti-diabetes agents on risk reduction; questioning the current diagnostic criteria.

Authors:  Esmaeil Mohammadi; Fatemeh Sadeghi Morasa; Shahin Roshani; Bagher Larijani; Farshad Farzadfar; Negar Rezaei; Sina Azadnajafabad; Sahar Saeedi Moghaddam; Mehrdad Azmin; Maryam Karimian; Nima Fattahi; Kosar Jamshidi; Narges Ebrahimi; Mahtab Rouhifard Khalilabad; Shohreh Naderimagham
Journal:  J Diabetes Metab Disord       Date:  2020-11-16

5.  Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage.

Authors:  Sina Azadnajafabad; Maryam Karimian; Shahin Roshani; Negar Rezaei; Esmaeil Mohammadi; Sahar Saeedi Moghaddam; Erfan Ghasemi; Fatemeh Sadeghi Morasa; Nazila Rezaei; Arya Aminorroaya; Ali Ghanbari; Maryam Nasserinejad; Fateme Gorgani; Bagher Larijani; Farshad Farzadfar
Journal:  J Diabetes Metab Disord       Date:  2020-11-10

6.  The Economic Burden of Smoking-Attribution and Years of Life Lost due to Chronic Diseases in Mashhad, 2015-2016.

Authors:  Mehdi Varmaghani; Malihe Ghobadi; Farshad Sharifi; Payam Roshanfekr; Ali Sheidaei; Masoume Mansouri; Amin Adel; Mohammad Mohammadi; Mohammad Reza Masjedi
Journal:  Int J Prev Med       Date:  2021-02-24

7.  Current Tobacco Smoking Prevalence Among Iranian Population: A Closer Look at the STEPS Surveys.

Authors:  Mohammad-Reza Sohrabi; Mohsen Abbasi-Kangevari; Ali-Asghar Kolahi
Journal:  Front Public Health       Date:  2020-12-16

8.  Introducing an efficient sampling method for national surveys with limited sample sizes: application to a national study to determine quality and cost of healthcare.

Authors:  Mahboubeh Parsaeian; Mahdi Mahdavi; Mojdeh Saadati; Parinaz Mehdipour; Ali Sheidaei; Shahab Khatibzadeh; Farshad Farzadfar; Saeid Shahraz
Journal:  BMC Public Health       Date:  2021-07-17       Impact factor: 3.295

9.  Opium use reporting error in case-control studies: neighborhood controls versus hospital visitor controls.

Authors:  Elham Mohebbi; Hamideh Rashidian; Ahmad Naghibzadeh Tahami; Ali Akbar Haghdoost; Afarin Rahimi-Movaghar; Monireh Sadat Seyyedsalehi; Abass Rezaianzadeh; Maryam Marzban; Abdolvahab Moradi; Mahin Gholipour; Maryam Hadji; Farin Kamangar; Kazem Zendehdel
Journal:  Med J Islam Repub Iran       Date:  2021-05-10

10.  Patterns of Obesity and Overweight in the Iranian Population: Findings of STEPs 2016.

Authors:  Shirin Djalalinia; Sahar Saeedi Moghaddam; Ali Sheidaei; Nazila Rezaei; Seyed Sina Naghibi Iravani; Mitra Modirian; Hossein Zokaei; Moein Yoosefi; Kimiya Gohari; Ahmad Kousha; Zhaleh Abdi; Shohreh Naderimagham; Ahmad Reza Soroush; Bagher Larijani; Farshad Farzadfar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.